Immuno-oncology 2.0 Roundtable

Immuno-oncolocgy 2.0 is here, yet numerous thorny challenges remain. Hear some of the most experienced, innovative thinkers discuss the key obstacles that still stand between the cell therapy industry and optimized commercial manufacture.